Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.
6 investors
Atomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs. The company applies computational approaches to advance RNA therapeutics.
6 investors
Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options. Its team includes a leadership team, board of directors, and scientific advisors experienced in drug development and company building.
6 investors
AuX Labs uses precision fermentation to produce recombinant milk proteins, starting with casein, that replicate the functional performance of dairy without animals. It sells these proteins to food manufacturers, CPG brands, and food-service operators for use in dairy products.
6 investors
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
6 investors
Avro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.
6 investors
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions. The company was founded in 2025 following a strategic combination of atai Life Sciences and Beckley Psytech.
6 investors
Better Dairy uses precision fermentation to produce bioactive milk proteins optimized for human development, targeting applications such as infant formulas that more closely mimic breastmilk and supplements for workout recovery. The company positions its proteins as more environmentally sustainable, requiring less greenhouse gas emissions and water than conventional dairy.
6 investors
Osteoboost is an FDA-cleared, drug-free prescription device that delivers precision vibration therapy to slow bone loss in postmenopausal women with osteopenia. The product targets bone density and strength loss in the spine and hip, backed by clinical trial data.
6 investors
Cache develops a platform for reliable long-term storage and access of biomolecules to support precision medicine and fundamental research. It aims to provide scalable, sustainable, and standardized biomolecule storage.
6 investors
California Cultured uses a natural cell-culture fermentation process to produce cocoa without conventional cacao farming, aiming to create chocolate free of contaminants such as lead and cadmium. It offers cultured cocoa to businesses for applications including high-flavanol products, custom flavor profiles, and co-branded launches in the food and chocolate industry.
6 investors
Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food. The company operates in cellular agriculture and food technology, with a FeedKind production plant in China run through its Calysseo partnership.
6 investors
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR. Its lead asset, ATX-304, is an AMPK Network Activator being developed for obesity and prediabetes.
6 investors
Cambrium designs and produces enzymes, polymers, and peptides using a molecular design platform and biological systems, aiming to create high-performance materials. It serves multiple industries including textiles, automotive, cosmetics, and construction where material performance is a priority.
6 investors
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
6 investors
Cellineobio develops cell engineering and bioprocess technology platforms. The company serves biotech and pharmaceutical research and manufacturing customers.
6 investors
CG Oncology is a clinical-stage biotechnology company developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer. Its lead investigational drug, cretostimogene, is an intravesically delivered immunotherapy being evaluated for non-muscle invasive bladder cancer (NMIBC).
6 investors
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma. It uses this data platform to discover and develop targeted therapies in ophthalmology for patients with these conditions.
6 investors
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
6 investors
Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.
6 investors
Circe uses a proprietary aerobic gas fermentation process to convert point-source CO₂ emissions into carbon-negative molecules that are drop-in equivalents of ingredients used in food, chemical, and fuel manufacturing. It serves industrial manufacturers across sectors and operates a pilot gas fermentation plant.
6 investors
Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer. Its product candidates aim to support an effective anti-tumor immune response.
6 investors
Conception develops stem cell technology to create functional reproductive cells in the laboratory, enabling in-vitro gametogenesis as a solution for individuals facing biological and medical fertility barriers.
6 investors
Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
6 investors